Skip to main content
editorial
. 2022 May 5;15(12):2161–2168. doi: 10.1093/ckj/sfac125

Table 2.

Ethical domains of practical considerations in xenotransplantation

Ethical domains
Autonomy Religious taboos against pigs Racial and ethnic attitudes Extent of informed consent Trans-species infection; chimerism Tracking infection risk Stigma of having a pig kidney
Equity Who will be in clinical trials Who will be eligible for xenotransplant Availability to groups excluded from transplant now Insurance coverage public and private Insurance coverage public and private Number of kidneys needed per transplant
Utility Oversight national, local; need for rules to conform Cost of program infrastructure and transplants Potential savings from xenotransplant over allotransplant Return on investment to commercial entities involved Concern for monopoly pricing if limited number of providers Hyperacute rejection Pig kidney response to human hormones
Xenotransplant regulatory oversight Approval of genetic changes Need for more animal models before human trials Allocation of pig kidneys Tracking pig kidney success Tracking infection risk
Justice Violate the laws of nature; cruelty to animals Lopsided distribution of healthcare spending Diversion of money away from primary care Who will be in clinical trials Who will be eligible for xenotransplant How to prevent hierarchy of kidneys and of recipients
Availability to groups excluded from transplant now Will government cover cost of immuno- suppression medications